Skip to main content
. Author manuscript; available in PMC: 2022 Jan 1.
Published in final edited form as: Surgery. 2020 Jul 24;169(1):34–42. doi: 10.1016/j.surg.2020.06.009

Figure 4.

Figure 4.

Lenvatinib resistance increases glycolysis and KU757 treatment attenuates glycolysis. Using the Seahorse XFe96 analyzer, glycolysis stress test was performed on WRO-LvR and WRO cells. Results indicate the upregulation of total glycolysis, glycolysis capacity, and glycolytic reserve in WRO-LvR cells compared to WRO cells that is reduced after treatment with KU757. The x-axis represents time since the start of the glycolysis stress test. Glucose was injected at 18 min, oligomycin was injected at 36 min and 2-DG was injected at 54 min.